Spanish Biotech Database

News in the Life Sciences Industry
Results 101 - 120 out of 137 displayed.
« 1 2 3 4 5 6 7 »

Phase 3 trial of isatuximab combination therapy showed 40% reduction in the risk of disease progression or death for patients with relapsed/refractory multiple myeloma

By: Nasdaq / GlobenewsWire - 02 Jun 2019

Positive results of lurbinectedin Phase II trial (PharmaMar) for the treatment of relapsed small cell lung cancer are presented at ASCO

MADRID, June 1, 2019 /PRNewswire/ -- The results of PharmaMar's (MSE: PHM) Phase II study with lurbinectedin as a single agent for the treatment of relapsed small cell lung cancer were presented today to the American Society of Clinical Oncology (ASCO) conference, which is currently being held... Read more ››

By: PR Newswire Association LLC. - 01 Jun 2019

Related companies: PHARMA MAR, S.A.

Novo Nordisk A/S - Share repurchase programme

By: Nasdaq / GlobenewsWire - 29 May 2019

Lundbeck increases its share capital by 26,098 shares (0.0131 % of outstanding shares) as a result of exercise of employee warrants

By: Nasdaq / GlobenewsWire - 22 May 2019

Information concerning the total number of voting rights and shares

By: Nasdaq / GlobenewsWire - 21 May 2019

Transactions with shares and linked securities in H. Lundbeck A/S made by executives and their closely associated parties

By: Nasdaq / GlobenewsWire - 21 May 2019

B. Braun Interventional Systems Announces U.S. Commercial Launch of NuDEL™ All-in-One Stent Delivery System for Treatment of Congenital Heart Defects

By: Nasdaq / GlobenewsWire - 20 May 2019

Transactions with shares and linked securities in H. Lundbeck A/S made by executives and their closely associated parties

By: Nasdaq / GlobenewsWire - 20 May 2019

B. Braun Announces $1 Billion Investment to Alleviate IV Fluid Shortages in the U.S. Healthcare System

By: Nasdaq / GlobenewsWire - 14 May 2019

Report on transactions with ALK-Abelló A/S B-shares and associated securities by managerial staff

By: Nasdaq / GlobenewsWire - 13 May 2019

Trading in Novo Nordisk shares by board members, executives and associated persons on 7 May 2019

By: Nasdaq / GlobenewsWire - 09 May 2019

Transactions with shares and linked securities in H. Lundbeck A/S made by executives and their closely associated parties

By: Nasdaq / GlobenewsWire - 09 May 2019

Three-month interim report (Q1) 2019

By: Nasdaq / GlobenewsWire - 09 May 2019

Double-digit growth for all strategic brands and DKK 4,234 million in revenue and DKK 1,200 million in EBIT

By: Nasdaq / GlobenewsWire - 08 May 2019

Novo Nordisk A/S purchases B shares worth DKK 2,235 million from Novo Holdings A/S under the 2019 share repurchase programme

By: Nasdaq / GlobenewsWire - 07 May 2019

Novo Nordisk A/S - Share repurchase programme

By: Nasdaq / GlobenewsWire - 07 May 2019

Allergy Therapeutics Publishes New Research Exploring Potential of its Adjuvant Systems in the Treatment of Cancer in the Journal of ImmunoTherapy of Cancer

By: Nasdaq / GlobenewsWire - 07 May 2019

Related companies: Allergy Therapeutics Italia S.R.L. | Allergy Therapeutics plc | Allergy Therapeutics Ibérica, SL

Sanofi : Dupixent® (dupilumab) Approved for Severe Asthma by European Commission

By: Nasdaq / GlobenewsWire - 07 May 2019

Lundbeck to acquire Abide Therapeutics, adding a unique discovery platform and a lead compound in an exploratory phase IIa program for Tourette’s

By: Nasdaq / GlobenewsWire - 06 May 2019

Novo Nordisk's operating profit increased by 14% in Danish kroner and by 8% at constant exchange rates (CER) in the first three months of 2019

By: Nasdaq / GlobenewsWire - 03 May 2019

« 1 2 3 4 5 6 7 »

Looking for companies outside of Spain?

Browse our global Life Sciences lead sourcing platform Biotechgate for company information, product pipelines, licensing opportunities, management details and much more.

Partners

Upcoming Life Sciences Events

October 2019
- Rennes: NutrEvent
- San Francisco: BIO Investor Forum
- Melbourne: Biotech-Pharma Product and Company Valuation - introduction

See Events »

Add an Event »

Latest company news

Novo Nordisk A/S – Share repurchase programme
21 Oct 2019 (Nasdaq / GlobenewsWire)

Sanofi: information concerning the total number of voting rights and shares, September 2019
21 Oct 2019 (Nasdaq / GlobenewsWire)

Novo Nordisk A/S – Share repurchase programme
14 Oct 2019 (Nasdaq / GlobenewsWire)

News in the Life Sciences Industry

Looking for companies outside of Spain?

Partners

Upcoming Life Sciences Events

Latest company news